Case series:anlotinib

6 trials

Sponsors

Peking University Third Hospital, Second Affiliated Hospital, Dalian Medical University, Sir Run Run Shaw Hospital Zhejiang University,School of Medicine, Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Peking University Shenzhen Hospital

Conditions

Lung CancerRecurrent or metastatic malignant tumors of the head and neckhepatocellular carcinomanone small cell lung cancerovarian cancer

Phase 1

Phase I-II clinical study for anlotinib in the treatment of brain metastases of non-small cell lung cancer

RecruitingChiCTR1800017929

Peking University Third Hospitalnone small cell lung cancer

Start: 2018-08-22Updated: 2018-08-27

Phase 2

A clinical observation for the efficacy and safety for capetabine and Anlotinib in recurrent or metastatic head and neck malignant tumors

Active, not recruitingChiCTR1800019932

Second Affiliated Hospital, Dalian Medical UniversityRecurrent or metastatic malignant tumors of the head and neck

Start: 2019-01-01Updated: 2018-12-10

The initial application of Anlotinib in liver transplantation patients of hepatocellular carcinoma beyond Milan criteria

Active, not recruitingChiCTR2000035520

Zhongshan Hospital affiliated to Fudan Universityhepatocellular carcinoma

Start: 2021-10-01Updated: 2020-08-17

Phase 4

Study for anlotinib in the treatment of brain metastasis of non-small cell lung cancer

Active, not recruitingChiCTR1900023190

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technologynone small cell lung cancer

Start: 2019-06-01Updated: 2019-05-20

Unknown Phase

Retrospective clinical observation for anlotinib hydrochloride in the treatment of retinal ovarian cancer

Active, not recruitingChiCTR1900020766

Sir Run Run Shaw Hospital Zhejiang University,School of Medicineovarian cancer

Start: 2019-02-01Updated: 2019-01-28

A real-world study for anlotinib in the treatment of advanced non-small cell lung cancer

RecruitingChiCTR2000032265

Peking University Shenzhen HospitalLung Cancer

Start: 2020-06-01Updated: 2020-06-08

Related Papers

The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer

Journal of Cancer Research and Clinical Oncology2021-08-0612 citations